Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Price weighting biases index behavior differently than market-cap methods. This overview explains the mechanics and the practical impact on portfolio results.
25,572 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
Navigator (NVGS) 2025 earnings paint a picture of a niche LNG carrier operator balancing utilization, rates and lever...
A 1949 recording captures the oldest known humpback song off Bermuda, offering a window into an ocean once times quie...
Retail traders drove a large share of leveraged ETF activity in late 2025 as markets swung. This piece examines the p...
An unauthorized mint triggered a depeg for Resolv’s stablecoin, with an attacker minting 80 million unbacked tokens a...
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
When the national debt climbs past the size of the economy, it can ripple through interest rates and monthly payments...
Trump Media posted a $405.9 million quarterly loss in Q1 2026, largely tied to unrealized cryptocurrency holdings, ev...
Meta's internal AI model is circulating a long-range Bitcoin forecast for end-2026, highlighting supply constraints, ...
As earnings season unfolds, SPIR investors want clarity on the drivers behind spire (spir) 2026 earnings. This guide ...
Could SoFi be the worst stock this year? This analysis highlights red flags, potential catalysts, and practical steps...